Waypoint Bio

Engineering cells with AI-powered models

New York, United States · Founded 2021 · $34.5M raised

Headquarters
New York, New York
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$34.5M
Last Round
$20.0M Series AJun 2026
Rounds
2

About

Waypoint Bio develops AI-designed CAR-T cell therapies for solid tumors using spatial pooled screening and proprietary machine learning. The platform tests thousands of therapy designs in vivo simultaneously, using spatial biology phenotyping and the Wayfinder LLM to rank and optimize cell therapy constructs. Based in New York, the company closed a $20M Series A in 2026.

Summary

Waypoint Bio is an Artificial Intelligence company based in New York, United States, founded in 2021. It has raised $34.5M in total across 2 rounds, most recently a $20.0M Series A round in Jun 2026. Investors include General Catalyst.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series ASeries AJun 2026
$20.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Waypoint Bio on Indexed.vc
<a href="https://indexed.vc/companies/waypoint-bio"><img src="https://indexed.vc/api/badge/company/waypoint-bio" alt="Waypoint Bio on Indexed.vc" width="260" height="76" /></a>